To Ablate Or Not To Ablate: Current Management of Atrial Fibrillation

OSUWexnerbloglogo2014 CME Webcast Discusses To Ablate Or Not To Ablate Current Management of Atrial Fibrillation. In 1998, Dr. Michel Hice-uh-gaire, a cardiologist in Bordeaux, France, determined that the electrical triggers for atrial fibrillation were most commonly located in the pulmonary veins and that he could cure atrial fibrillation by ablating these triggers with a catheter. In the 2 decades since, ablation has a key element in the cardiologist’s toolbox to treat atrial fibrillation. But which patients are best served by medical treatment and which ones are best treated with catheter ablation? On this CME webcast, we’re going to explore this question. Joining our moderator is cardiac electrophysiologist and Professor of Internal Medicine at the Ohio State University, Dr. John Hummel.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: Understand the risks of atrial fibrillation; and Understand when to initiate a strategy to maintain sinus rhythm.

You’ll also learn about the following:

  • Clinical implications of atrial fibrillation
  • Patient selection for atrial ablation
  • The ablation procedure
  • Return to work and exercise
  • Medication management after atrial ablation
  • Maze procedure
  • Management of recurrent atrial fibrillation after an ablation procedure
  • Apple Watch EKG app

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Teaches on Immunosuppressant Medications

OSUWexnerbloglogo2014 CME Webcast Teaches on Immunosuppressant Medications. More and more, primary care physicians and hospitalists are finding themselves taking care of patients who have been started on immunosuppressant medication a transplant physician, rheumatologist, nephrologist, or pulmonologist. On this CME webcast, we’re going to tell you what you need to know about these medications, their side effects, and their complications. Let me introduce our guests. Dr. Brian Keller is a lung transplant pulmonologist and Assistant Professor Internal Medicine at The Ohio State University. And Pamela Burcham is a lung transplant specialty pharmacist from the OSU Wexner Medical Center.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DISCUSS indications for immunosuppressive therapies; and DESCRIBE prophylaxis immunization, and pregnancy considerations for patients on Immunosuppressive therapy; UNDERSTAND the indications for individual immunosuppressants; and DESCRIBE the common adverse effects and monitoring parameters of the immunosuppressive medications.

You’ll also learn about the following:

  • Common indications for immunosuppressant medications
  • Commonly used immunosuppressant medications
  • Food safety for patients taking immunosuppressant medications
  • Pneumocystis jiroveci clinical presentation
  • Indications for TNF inhibitors
  • Infection risk of TNF inhibitors
  • Management of immunosuppressants in the perioperative period
  • Travel safety when taking an immunosuppressant
  • Bone health and corticosteroids
  • Eye health and corticosteroids
  • Monitoring for methotrexate-induced hepatotoxicity
  • Thiopurine methylytransferase
  • Cyclophosphamide

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

On-line Enduring Material Provides Guidance on Cancer Prevention

OSUWexnerbloglogo2014 On-line Enduring Material Provides Guidance on Cancer Prevention. Most cancers can be prevented by changing behaviors at an early age, by appropriate vaccinations, and by detection of pre-cancerous conditions. On this CME webcast, we are going to show you how to prevent cancer in your own patients. Joining our moderator in the studio are cancer prevention experts from the Ohio State University. Dr. Electra Paskett is a Professor and the Director of the Division of Cancer Prevention and Control. And Dr. Darrell Gray is a gastroenterologist and an Assistant Professor of Internal Medicine.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND evidence-based cancer prevention recommendations; and DEVELOP ways to integrate evidence-based cancer prevention and early detection recommendations in clinical practice.

You’ll also learn about the following:

  • Brief overview of causes of cancer
  • Screening for pre-cancerous conditions
  • Lung cancer screening programs
  • Improving colon cancer screening rates
  • Addressing racial disparities in childhood obesity
  • Experiences with cancer screening in Appalachia

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About New Drugs for Lipid Management

OSUWexnerbloglogo2014 Learn About New Drugs for Lipid Management. Managing hyperlipidemia used to be so easy. If a patient’s total cholesterol was greater than 200, then we started them on lovastatin to reduce it. But things are a lot more complicated now. There isn’t a single cholesterol target for all patients and we have gone way beyond statins as the only game in town for cholesterol management. On this CME webcast, we’re going to update you on the newest developments in lipid management. What tests to order, who to treat and which drugs to use. Joining our moderator in the studio is cardiologist and Associate Professor of Internal Medicine, Dr. John Larry and pharmacist and Assistant Professor of Pharmacy, Melissa Snider.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: REVIEW updates in approaches to treatment of dyslipidemia; DISCUSS recent evidence for non-statin lipid lowering therapies; DISCUSS place in therapy of available lipid lowering therapies; and REVIEW clinical approach to statin intolerance.

You’ll also learn about the following:

  • Patient-specific cholesterol targets
  • Multidisciplinary lipid clinics at the OSU Wexner Medical Center
  • The expanding role of pharmacists in outpatient clinical practice
  • Diet and cholesterol

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Understanding the Management of Depression

OSUWexnerbloglogo2014 Understanding the Management of Depression. We now have more and better medications to treat depression than the anti-tuberculosis drug created in the 1950’s. We also have much better ways to screen and identify patients with depression. We’re pleased to welcome our guests today to tell us about depression in primary care. Dr. Nazhat Taj-Schaal is an Assistant Professor of Internal Medicine in the Division of General Internal Medicine and Kelli Barnes is a pharmacist and Assistant Professor in the College of Pharmacy.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: REVIEW recent updated clinical guidelines that address screening for depression, monitoring treatment effects, and integration of behavioral health into primary care; and REVIEW medication treatment options, their unique characteristics and how to choose between different therapies.

You’ll also learn about the following:

  • Epidemiology of depression
  • Different antidepressants have different properties
  • Managing depressed patients in a busy primary care practice
  • Identifying the suicidal patient
  • Practical approach to antidepressant selection
  • Setting realistic expectations for antidepressant effects

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.